Milestone Fees. Except with respect milestone fees triggered upon a NADA filing, within [***] days after the occurrence of the following milestones, Licensee will pay Licensor the corresponding one-time milestone fees provided below. With respect to any milestone fee based on a NADA filing, Licensee will pay Licensor the corresponding one-time milestone fee provided below for such NADA filing within [***] months after such NADA filing. For avoidance of doubt, the parties agree that Licensee’s obligation to pay each milestone fee referenced below is a one-time obligation even if the applicable milestone event occurs more than once. Milestone Milestone Fee [***] [***] US Dollars ($[***]) [***] [***] US Dollars ($[***]) [***] [***] US Dollars ($[***]) [***] [***] US Dollars ($[***]) [***] [***] US Dollars ($[***])
Appears in 3 contracts
Samples: Exclusive Ip License Agreement (Aratana Therapeutics, Inc.), Exclusive Ip License Agreement (Aratana Therapeutics, Inc.), Exclusive Ip License Agreement (Aratana Therapeutics, Inc.)
Milestone Fees. Except with respect milestone fees triggered upon a NADA filing, within [***] days after the occurrence of the following milestones, Licensee will pay Licensor the corresponding one-time milestone fees provided below. With respect to any milestone fee based on a NADA filing, Licensee will pay Licensor the corresponding one-time milestone fee provided below for such NADA filing within [***] months after such NADA filing. For avoidance of doubt, the parties agree that Licensee’s obligation to pay each milestone fee referenced below is a one-time obligation even if the applicable milestone event occurs more than once. Milestone Milestone Fee [***] [***] US Dollars ($[***]) [***] [***] US Dollars ($[***]) [***] [***] US Dollars ($[***]) [***] [***] US Dollars ($[***]) [***] [***] US Dollars ($[***]) [***] [***] US Dollars ($[***]) [***] [***] US Dollars ($[***]) [***] [***] US Dollars ($[***])
Appears in 2 contracts
Samples: Exclusive Ip License Agreement (Aratana Therapeutics, Inc.), Exclusive Ip License Agreement (Aratana Therapeutics, Inc.)